NeuroPace (NPCE) Assets (2020 - 2026)
NeuroPace's (NPCE) quarterly Assets came in at $98.9 million in Q1 2026, down 10.26% year-on-year from $110.2 million in Q1 2025, and down 6.32% quarter-over-quarter from $105.6 million in Q4 2025.
NeuroPace (NPCE) Assets (2020 - 2026) Analysis & Trends
NeuroPace's Assets history runs 7 years deep, the most recent figure standing at $98.9 million for Q1 2026.
- On a quarterly basis, Assets fell 10.26% year-over-year to $98.9 million in Q1 2026; TTM through Mar 2026 was $98.9 million, a 10.26% decrease from a year earlier, with the FY2025 full-year figure at $105.6 million, up 11.54% from the prior year.
- Assets declined to $98.9 million in Q1 2026 per NPCE's latest filing, from $105.6 million in the prior quarter.
- Across five years, Assets topped out at $129.0 million in Q1 2022 and bottomed at $94.4 million in Q2 2024.
- The 5-year median for Assets is $106.1 million (2025), against an average of $106.5 million.
- Biggest YoY gain for Assets was 156.3% in 2022; the steepest drop was 19.34% in 2022.
- Year by year, Assets stood at $114.1 million in 2022, then slipped by 5.66% to $107.7 million in 2023, then fell by 12.08% to $94.6 million in 2024, then increased by 11.54% to $105.6 million in 2025, then declined by 6.32% to $98.9 million in 2026.
- Per Business Quant, the three latest NPCE Assets figures stand at $98.9 million (Q1 2026), $105.6 million (Q4 2025), and $107.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | 110.43 Bn |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | 46.29 Bn |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 93.03 Bn |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 44.35 Bn |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 13.32 Bn |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 6.63 Bn |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | 37.13 Bn |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | 10.46 Bn |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | 31.92 Bn |
| 10 | NeuroPace | 517.38 Mn | 463.40 Mn | 18.05 Mn | 98.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98.90 Mn |
| Dec 31, 2025 | 105.57 Mn |
| Sep 30, 2025 | 107.26 Mn |
| Jun 30, 2025 | 106.11 Mn |
| Mar 31, 2025 | 110.21 Mn |
| Dec 31, 2024 | 94.65 Mn |
| Sep 30, 2024 | 96.30 Mn |
| Jun 30, 2024 | 94.39 Mn |
| Mar 31, 2024 | 98.85 Mn |
| Dec 31, 2023 | 107.65 Mn |
| Sep 30, 2023 | 99.30 Mn |
| Jun 30, 2023 | 102.23 Mn |
| Mar 31, 2023 | 106.27 Mn |
| Dec 31, 2022 | 114.11 Mn |
| Sep 30, 2022 | 120.47 Mn |
| Jun 30, 2022 | 118.54 Mn |
| Mar 31, 2022 | 128.98 Mn |
| Dec 31, 2021 | 133.56 Mn |
| Sep 30, 2021 | 141.26 Mn |
| Jun 30, 2021 | 146.97 Mn |